AFP-L3, the core-fucosylated N-glycoform of AFP, is an established marker of HCC risk [39] and Debruyne et al. [21] showed that alpha-1,3-fucosylated triantennary N-glycans associated with hemopexin increase in HCC compared to the disease-free, fibrotic, and cirrhotic patients. Here, AFP is linked to hepatocellular carcinoma.